XML 41 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Revenue - Revenue from Licensing Arrangements (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2019
Collaborative Arrangements and Co-Promote Agreement      
Total revenue $ 10,417 $ 13,196  
Pfizer      
Collaborative Arrangements and Co-Promote Agreement      
Initial cash payment     $ 10,000
Total revenue   $ 2,500  
Pfizer | Sales milestones      
Collaborative Arrangements and Co-Promote Agreement      
Initial cash payment $ 237,500